Current and historical daily PE Ratio for Hainan Shuangcheng Pharmaceuticals Co Ltd (
) from 2012 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hainan Shuangcheng Pharmaceuticals stock (SZSE:002693) PE ratio as of Jun 05 2024 is 0.
More Details
Hainan Shuangcheng Pharmaceuticals Co Ltd (SZSE:002693) PE Ratio (TTM) Chart
Hainan Shuangcheng Pharmaceuticals Co Ltd (SZSE:002693) PE Ratio (TTM) Historical Data
View and export this data going back to 2012. Start your Free Trial
Total 1198
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Hainan Shuangcheng Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-05 | At Loss | 2024-03-27 | At Loss |
| 2024-06-04 | At Loss | 2024-03-26 | At Loss |
| 2024-06-03 | At Loss | 2024-03-25 | At Loss |
| 2024-05-31 | At Loss | 2024-03-22 | At Loss |
| 2024-05-30 | At Loss | 2024-03-21 | At Loss |
| 2024-05-29 | At Loss | 2024-03-20 | At Loss |
| 2024-05-28 | At Loss | 2024-03-19 | At Loss |
| 2024-05-27 | At Loss | 2024-03-18 | At Loss |
| 2024-05-24 | At Loss | 2024-03-15 | At Loss |
| 2024-05-23 | At Loss | 2024-03-14 | At Loss |
| 2024-05-22 | At Loss | 2024-03-13 | At Loss |
| 2024-05-21 | At Loss | 2024-03-12 | At Loss |
| 2024-05-20 | At Loss | 2024-03-11 | At Loss |
| 2024-05-17 | At Loss | 2024-03-08 | At Loss |
| 2024-05-16 | At Loss | 2024-03-07 | At Loss |
| 2024-05-15 | At Loss | 2024-03-06 | At Loss |
| 2024-05-14 | At Loss | 2024-03-05 | At Loss |
| 2024-05-13 | At Loss | 2024-03-04 | At Loss |
| 2024-05-10 | At Loss | 2024-03-01 | At Loss |
| 2024-05-09 | At Loss | 2024-02-29 | At Loss |
| 2024-05-08 | At Loss | 2024-02-28 | At Loss |
| 2024-05-07 | At Loss | 2024-02-27 | At Loss |
| 2024-05-06 | At Loss | 2024-02-26 | At Loss |
| 2024-04-30 | At Loss | 2024-02-23 | At Loss |
| 2024-04-29 | At Loss | 2024-02-22 | At Loss |
| 2024-04-26 | At Loss | 2024-02-21 | At Loss |
| 2024-04-25 | At Loss | 2024-02-20 | At Loss |
| 2024-04-24 | At Loss | 2024-02-19 | At Loss |
| 2024-04-23 | At Loss | 2024-02-08 | At Loss |
| 2024-04-22 | At Loss | 2024-02-07 | At Loss |
| 2024-04-19 | At Loss | 2024-02-06 | At Loss |
| 2024-04-18 | At Loss | 2024-02-05 | At Loss |
| 2024-04-17 | At Loss | 2024-02-02 | At Loss |
| 2024-04-16 | At Loss | 2024-02-01 | At Loss |
| 2024-04-15 | At Loss | 2024-01-31 | At Loss |
| 2024-04-12 | At Loss | 2024-01-30 | At Loss |
| 2024-04-11 | At Loss | 2024-01-29 | At Loss |
| 2024-04-10 | At Loss | 2024-01-26 | At Loss |
| 2024-04-09 | At Loss | 2024-01-25 | At Loss |
| 2024-04-08 | At Loss | 2024-01-24 | At Loss |
| 2024-04-03 | At Loss | 2024-01-23 | At Loss |
| 2024-04-02 | At Loss | 2024-01-22 | At Loss |
| 2024-04-01 | At Loss | 2024-01-19 | At Loss |
| 2024-03-29 | At Loss | 2024-01-18 | At Loss |
| 2024-03-28 | At Loss | 2024-01-17 | At Loss |
Hainan Shuangcheng Pharmaceuticals Co Ltd (SZSE:002693) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Hainan Shuangcheng Pharmaceuticals Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100001K63
Share Class Description:
SZSE:002693: Class ACompare
Compare
Traded in other countries / regions
002693.China IPO Date
2012-08-08Description
Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers